Altace

This page contains recent news articles, when available, and an overview of Altace but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Altace
(when available)

Pharmacology and use:
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor similar to benazepril, fosinopril, and quinapril. An inactive prodrug, ramipril is converted to ramiprilat in the liver and is used to treat hypertension and heart failure, to reduce proteinuria and renal disease in patients with nephropathies, and to prevent stroke, myocardial infarction, and cardiac death in high-risk patients. Indicated for diuretics and digitalis in congestive heart failure as adjunctive therapy; prophylaxis in post MI.

Mechanism Of Action:
Ramiprilat, the active metabolite, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blood pressure and an increase in plasma renin. Ramiprilat may also act on kininase II, an enzyme identical to ACE that degrades the vasodilator bradykinin.

News Articles on Ramipril

King Pharma 2Q Net Falls 6.9%; Alpharma Deal Credited >KG  -  ‎Aug 6, 2009‎
Branded-pharmaceutical sales dropped 13% amid continued sales evaporation of Altace. Revenue slumped after King lost a patent case in late 2007. Wall Street Journal

Drug stocks join broader market rally; King up second day  -  ‎Aug 7, 2009‎
On Thursday, King said that its second-quarter profit fell, due largely to generic competition for Altace, one of its best-selling products. MarketWatch

US HOT STOCKS: Chiquita, CBS, Crox Active In Late Trading  -  ‎Aug 6, 2009‎
...results beat analysts' estimates, as generic versions of the company's formerly best-selling Altace blood-pressure treatment continued to hurt sales. Wall Street Journal

King's Embeda Cleared as Abuse-Resistant Painkiller  -  ‎Aug 13, 2009‎
...as investors wait for new products to replace revenue lost when its former top-selling heart pill Altace went generic in late 2007. Bloomberg

King Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript  -  ‎Aug 7, 2009‎
Total selling, general and administrative expense excluding special items and our co-promotion fee for Altace was $119 million in the second quarter of 2009 Seeking Alpha

BUYINS.NET: (WYE) SqueezeTrigger Price is $48.060. There is ...  -  ‎Aug 28, 2009‎
...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release)

AIG, HIG, GNW, CSIQ, HSNI, KG, CHUX, VITA Popular Stocks  -  ‎Aug 6, 2009‎
...results beat analysts' estimates, as generic versions of the company's formerly best-selling Altace blood-pressure treatment continued to hurt sales. Ub News

æ²™å?¦ç±»è?¯ç‰©é”€å”®å‡?å°‘70亿美元 é?¢ä¸´è¢«ä»¿ä¹‹ç—›  -  ‎Aug 4, 2009‎
...是将阿é½?æ²™å?¦æˆ–其与氯噻酮组æˆ?çš„å¤?方制剂和其他诸如代文和奥美沙å?¦é…¯ä¹‹ç±»çš„æ²™å?¦ç±»è?¯ç‰©å’Œè¯¸å¦‚辉瑞的络活喜(Norvasc)和国王制è?¯çš„雷米普利(Altace)等进行比较。 中国食品商务网

King Pharmaceuticals legt Zahlen für das zweite Quartal vor  -  ‎Aug 6, 2009‎
Im Pharmasegment hatte der Konzern nach wie vor unter Generika-Konkurrenz für sein Bluthochdruckmittel Altace zu leiden und verzeichnete hier einen AktienCheck

Buy cheap Altace Information , side effects, online pills  -  ‎Jun 30, 2009‎
Altace is in a group of drugs called ACE inhibitors. ACE stands for angiotensin converting enzyme. Altace is used to treat high blood pressure На плувка и дъно

WhisperfromWallStreet.com Afternoon Stock Report - KG - King  -  ‎Jul 9, 2009‎
...acute care products that comprise Bicillin and Intal; and legacy products consisting of Altace, Levoxyl, and Cytomel to general/family practitioners, TransWorldNews (press release)

Watson Pharmaceuticals to purchase Arrow Group  -  ‎Jun 18, 2009‎
The company sells a generic version of the blood pressure drug Altace and is among the generic drug makers challenging AstraZeneca's patent on the asthma The Star-Ledger - NJ.com

Shop around before you buy generic drugs  -  ‎Jun 23, 2009‎
The generic version of Altace costs $167.89 at Walgreen's but at Costco we pay only $17.45.That's a savings of $150. Accupril's generic version costs $84.59 abc13.com

Painkillers are 'safe and effective'  -  ‎Jun 26, 2009‎
...the company has recently recorded a first quarter loss after struggling with generic competition for one of its biggest selling drugs Altace. Hays Pharma

tramadol 50 mg tablets  -  ‎Jun 23, 2009‎
Interaction Paxil Altace Hospitality till the following tramadol 50 mg tablets letter, the ring, and then it was that edward would not interest. Glace Bay Gleaner

BUYINS.NET: BLUD, NVO, RBN, ROS, SNY, CPII. Abnormal Price ...  -  ‎Jun 26, 2009‎
Its primary medicines include Lovenox/Clexane, Plavix/Iscover, Aprovel/Avapro/Karvea, Tritace/Triatec/Delix/Altace, Lantus, Amaryl/Amarel/Solosa, Acomplia, Trading Markets (press release)

SNY-A Sanofi Safety Scare?  -  ‎Jun 26, 2009‎
Its primary medicines include Lovenox/Clexane, Plavix/Iscover, Aprovel/Avapro/Karvea, Tritace/Triatec/Delix/Altace, Lantus, Amaryl/Amarel/Solosa, Acomplia, TransWorldNews (press release)

King Pharmaceuticals Inc.  -  ‎Jul 6, 2009‎
...acute care products that comprise Bicillin and Intal; and legacy products consisting of Altace, Levoxyl, and Cytomel to general/family practitioners, TransWorldNews (press release)

Watson将以17.5亿美元收购Arrow Group  -  ‎Jun 17, 2009‎
Watson首席执行官ä¿?罗·比è?¨ç½—(Paul Bisaro)表示,Arrow还出售é™?血压è?¯ç‰©Altace(å?ˆå??ramipril)的一个仿制版本。此外,Arrow还是对阿斯利康公å?¸(AZN)哮喘è?¯ç‰©Pulmicortçš„ 新浪网

ווטסון תרכוש ×?ת יצרנית התרופות הגנריות ×?רו גרופ - תמורת 1.7 ...  -  ‎Jun 18, 2009‎
...×?רו מוכרת ×’×? ×?ת הגרסה הגנרית לתרופה להורדת לחץ הד×? Altace, כך לפי מנכ"ל ווטסון פול ביס×?רו. לדבריו, ווטסון עושה עסקי×? רק ב×?רצות הברית, ×?בל ×?רו ×’×? משווקת כלכליסט

Watson將以17.5億美元收購Arrow Group  -  ‎Jun 17, 2009‎
Watson首席執行官ä¿?羅·比薩羅(Paul Bisaro)表示,Arrow還出售é™?血壓藥物Altace(å?ˆå??ramipril)的一個仿制版本。此外,Arrow還是å°?阿斯利康公å?¸(AZN)哮喘藥物Pulmicortçš„ 新浪網

最具潜力å??大新è?¯  -  ‎Jun 17, 2009‎
...此外国王于2007å¹´12月失去雷米普利(Altace)ä¿?护以å?Šç¾Žä»–沙酮(Skelaxin)é?¢ä¸´é?žä¸“利è?¯ç‰©å?¯èƒ½çš„市场准入,使得国王更加ä¾?赖这些新产å“?的批准。 生物通

Patient in quandary whether to take hormone  -  ‎Apr 18, 2009‎
Brand names of some of these drugs are Lotensin, Capoten, Vasotec, Monopril, Zestril, Univasc, Aceon, Accupril, Altace and Mavik. Cough is one of their side SouthCoastToday.com

FDA Safety Changes: Luvox, Altace, Capozide, Monopril, Furadantin  -  ‎Apr 8, 2009‎
Updated monographs include those for ramipril tablets and capsules (Altace, King Pharmaceuticals, Inc), captopril plus hydrochlorothiazide tablets (Capozide Medscape

King Reports Fourth-Quarter Loss on Alpharma Purchase  -  ‎Feb 26, 2009‎
Loss of patent protection for the blood-pressure pill Altace in late 2007 led King to shift its focus to neuroscience. The company formed two partnerships Bloomberg

Ranbaxy gets US FDA nod for cardiovascular drugs  -  ‎Mar 8, 2009‎
Ramipril, which can also be used for treating hypertension, is a bioequivalent to King Pharmaceuticals' Altace drug. The drug will be available in the Hindu

Seeking Gain From Pain  -  ‎Mar 3, 2009‎
First, patent expiration is crushing sales of King's former best-seller, the hypertension medication Altace, which has fallen from $646 million in 2007 Motley Fool

Closing Bell  -  ‎Mar 9, 2009‎
The US FDA determined the Ranbaxy formulations to be bioequivalent and as having the same therapeutic effect as that of the reference listed drug, Altace, Economic Times

Janssen reps sue, alleging off-label Risperdal push; MannKind to ...  -  ‎Mar 9, 2009‎
Release > Ranbaxy Laboratories got final FDA approval to sell its version of the King Pharmaceuticals cardiovascular drug Altace, the third approval for FiercePharma

Novartis says strong dollar to weaken earnings; Biovail founder ...  -  ‎Feb 26, 2009‎
...largely due to the costs of acquiring rival Alpharma, but also because its Altace painkiller went off patent a year ago, causing sales to drop. FiercePharma

Weis Markets Expands Low-Cost Prescription Plan  -  ‎Feb 19, 2009‎
...cholesterol, diabetes, infections and digestive ailments and the new generic drug Altace, which is used to treat high blood pressure and heart failure. PR Newswire (press release)

King Pharmaceuticals muss Verlust ausweisen  -  ‎Feb 26, 2009‎
Der Umsatzrückgang resultierte dabei vor allem aus zuletzt durch Konkurrenten vertriebene Generika-Versionen des Bluthochdruck-Medikaments Altace. Stock World

King Pharmaceuticals Cuts 22% of Work Force  -  Feb 3, 2009
Since it lost a 2007 patent case involving its once top-selling Altace blood-pressure drug, King had shifted its focus onto other products, Wall Street Journal

King Pharmaceuticals to lay off 70 at Bristol headquarters  -  Jan 30, 2009
King went through a similar downsizing in late 2007 — cutting 20 percent of its work force — when patents on its branded hypertension drug Altace led to its Kingsport Times News,

King Pharmaceuticals plans to appeal loss of patent for Skelaxin  -  Jan 21, 2009
King, which employs about 500 people at its Bristol headquarters, survived an even bigger hit in September 2007 when its hypertension drug Altace went Kingsport Times News,

Free ringtones tmobile  -  Jan 17, 2009
Know gardner p pediatric news views aciphex prescription phentermine altace free ringtones tmobile generic ciales going the free ringtones tmobile at about Griggs County Courier,

Doxycycline purchase  -  Jan 17, 2009
Know gardner p pediatric news views aciphex prescription phentermine altace doxycycline purchase generic ciales going the doxycycline purchase at about Griggs County Courier,

Buy androgel  -  Jan 17, 2009
Know gardner p pediatric news views aciphex prescription phentermine altace buy androgel generic ciales going the buy androgel at about information. Griggs County Courier,

Oxycodone pills  -  Jan 17, 2009
Know gardner p pediatric news views aciphex prescription phentermine altace oxycodone pills generic ciales going the oxycodone pills at about information. Griggs County Courier,

Blood pressure medicine can cause hacking cough  -  Dec 22, 2008
Like other blood pressure drugs in this class (Accupril, Altace, benazepril, captopril, enalapril, ramipril and quinapril), lisinopril can cause a hacking Los Angeles Times,

Medicine triggers hallucinations  -  Dec 22, 2008
Like other blood pressure drugs in this class (Accupril, Altace, benazepril, captopril, enalapril, ramipril and quinapril), lisinopril can cause cough as an Online Athens,

Pain Therapeutics, King Fall as Drug to Thwart Abuse Is Delayed  -  Dec 11, 2008
King is under pressure from investors to introduce new drugs to replace revenue lost after its top-selling heart pill Altace went generic last year, Bloomberg

December 2008 Mayo Clinic Health Letter Highlights: Colorectal ...  -  Dec 9, 2008
Altace (ramipril) for blood pressure and heart failure -- Ambien (zolpidem), a sleep aid -- Depakote (divalproex) for seizures, migraines and bipolar MarketWatch

Sanofi-Aventis : un nouveau site à Floirac  -  Dec 15, 2008
Lantus, Copaxone, Aprovel, Avapro, Karvea, Tritace, Triatec, Delix, Altace, Allegra, Telfast, Amaryl, Amarel, Solosa, Xatral, Actonel, Dépakine. Échos Judiciaires Girondins,

Pharma company poised to introduce new drug therapies  -  Sep 24, 2008
Driving the decline was a drop in sales of Altace of nearly $120 million. Although King announced a 20% reduction in the US salesforce following the adverse Stockhouse,

Alpharma rejects King Pharma's $37 per share sweetened offer - Update  -  Sep 26, 2008
The proposal comes, as King Pharma is trying to reposition itself, as generic competition eroded sales of its best-selling blood pressure drug Altace. Trading Markets (press release),

Weis Markets Completes Rollout of New 90-Day $9.99 Prescription ...  -  Oct 3, 2008
Weis Markets' 90-Day Prescription plan includes the new generic drug Altace, which is used to treat high blood pressure and heart failure. SYS-CON Media,

[계ì˜?ê·œ 칼럼]걷기와 소ì‹?(å°?食)ì?˜ 기ì ?  -  Sep 28, 2008
...그러다 7 년 전부터는 혈압까지 정�치 보다 높다 하여 혈압 약(Altace 5mg)까지 매� 한 알씩 추가로 복용 하게 �었다. 결국 약물만으로는 병� 났기는 커녕 세월� �나다 밴쿠버 중앙�보,

There are a number of ways to fight restless legs  Sep 13, 2008
ACE inhibitors include Vasotec, enalapril, captopril, Accupril, Altace and Mavik. If you are not sure about your medicine's safety with potassium,SouthCoastToday.com,

King's Unstoppable Urge to Merge  Sep 12, 2008
Hypertension treatment Altace has begun to face generic competition, and muscle relaxant Skelaxin will face generic competition sooner than expected.Motley Fool

Market Likes Alpharma’s Rejection of King’s Rich Offer  Aug 22, 2008
Last year, the company lost a patent lawsuit over its best-selling blood-pressure drug Altace. Earlier this month, the company said its second-quarter netWall Street Journal Blogs,

Alpharma reports positive Embeda pain drug data  Sep 9, 2008
King is eager to expand its presence in the pain drug market as sales of its blood pressure drug Altace reel from the impact of generic rivals.guardian.co.uk,

Understanding hypertension  Aug 18, 2008
We have medicines that inhibit the action of the kidney (such as Altace and Enalapril) and that block the places on the muscle where the hormone attachesStaten Island Advance - SILive.com,

Throat and Tongue Swelling Can Be Lethal  Aug 17, 2008
Lotensin, captopril, Vasotec, Lisinopril, Prinivil, Monopril, Zestril, Accupril, Altace and Mavik are examples. Other medicines involved in angioedema areRedOrbit,

King Pharma offers $33 a share for Alpharma  Aug 22, 2008
The proposal comes, as King Pharma is trying to reposition itself, as generic competition eroded sales of its best-selling blood pressure drug Altace.Trading Markets (press release),

Pfizer may take over King Pharmaceuticals, analysts say  -  06 Aug 2008
Pfizer may acquire King Pharmaceuticals, maker of the blood-pressure drug Altace, some analysts said. Representatives for both companies declined to comment SmartBrief,

King Options Surge on Takeover Rumors  -  Aug 5, 2008
The firm makes money on its Altace blood-pressure pills, but recently shifted its focus to painkillers after its patent was taken away. LEAPSInvestor.com,

Would Pfizer Buy King Pharmaceuticals?  -  Aug 5, 2008
King, which sells the Altace blood-pressure pill, shifted its focus to painkillers after a court ruling invalidated the drug’s patent last fall, Pharmalot,

Lupin net up 101% at Rs 112 crore  -  Jul 22, 2008
King Pharmaceutical's branded product of Ramipril - Altace capsules, had an annual sales of $ 920 million in 2007. Lupin's advanced markets formulation Business Standard,

Pharma Q1 show to stay robust  -  Jul 16, 2008
King Pharmaceutical's branded ramipril product, Altace, had sales of $920 million in 2007. Ranbaxy Laboratories, Glenmark, Zydus Cadila and Aurobindo are Business Standard,

Gannon On Investing's July 2008 Blogger Roundtable  -  Jul 21, 2008
The stock got hammered, primarily because it lost patent protection for its largest drug (a heart drug called Altace) in 2007. King's strategy is to acquire Seeking Alpha,

BUYINS.NET: (WYE) SqueezeTrigger Price is $44.892. There is ...  -  Jul 23, 2008
...including EFFEXOR (marketed as EFEXOR internationally) and EFFEXOR XR; cardiovascular products, including ALTACE (co-promoted with King Pharmaceuticals, Trading Markets (press release),

Fundasalud registró 8.539 sucrenses con hipertensión  -  Jul 26, 2008
Los fármacos prescritos a los hipertensos son el Norvasc, Coraspirina, Lanicor y Altace, entre otros. Para recibir tratamiento contra la hipertensión, El Tiempo de Venezuela,

Brand Names/Synonyms:
Altace is also known by the following brand names and/or synonymsAcovil; Altace; Carasel; Cardace; Delix; HOE 498; Hytren; Lostapres; Pramace; Quark; Ramace; Ramipril; Ramipril [Usan:Ban:Inn]; Ramiprilum [Latin]; Triatec; Tritace; Unipril; Vesdil

Drug Category:
Altace is categorized under the following by the FDA: Antihypertensive Agents; Angiotensin-converting Enzyme Inhibitors; ATC:C09AA05

Dosage Forms:
CAPSULE

Absorption:
The extent of absorption is at least 50-60% and is not significantly influenced by the presence of food in the GI tract, although the rate of absorption is reduced.

Interactions:
Interactions for Ramipril:

With nonsteroidal anti-inflammatory agents: Rarely, concomitant treatment with ACE inhibitors and nonsteroidal anti-inflammatory agents have been associated with worsening of renal failure and an increase in serum potassium.

With Diuretics: Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ramipril. The possibility of hypotensive effects with ramipril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ramipril. If this is not possible, the starting dose should be reduced.

With Potassium Supplements and Potassium-sparing Diuretics: Ramipril can attenuate potassium loss caused by thiazide diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored frequently.

With Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium. These drugs should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended. If a diuretic is also used, the risk of lithium toxicity may be increased.

Other: Neither ramipril nor its metabolites have been found to interact with food, digoxin, antacid, furosemide, cimetidine, indomethacin, and simvastatin. The combination of ramipril and propranolol showed no adverse effects on dynamic parameters (blood pressure and heart rate). The co-administration of ramipril and warfarin did not adversely affect the anticoagulant effects of the latter drug. Additionally, co-administration of ramipril with phenprocoumon did not affect minimum phenprocoumon levels or interfere with the subjects' state of anti-coagulation.





Chemical IUPAC Name:
4-[2-(1-ethoxycarbonyl-3-phenyl-propyl)aminopropanoyl]-4-azabicyclo[3.3.0]octane-3-carboxylicacid

:
 
Web health.mongabay.com/health


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com


COPYRIGHT 2007 MONGABAY.COM